Computational Methods to Study Human Transcript Variants in COVID-19 Infected Lung Cancer Cells

Jiao Sun, Naima Ahmed Fahmi, Heba Nassereddeen, Sze Cheng, Irene Martinez, Deliang Fan, Jeongsik Yong, Wei ZhangInternational Journal of Molecular Sciences 2021 · DOI

TL;DR

This study introduces computational methods to analyze transcript variants (alternative splicing and polyadenylation) in lung cancer cells infected with SARS-CoV-2. They found that viral infection significantly alters these transcript variants, revealing distinct molecular signatures and biological pathways not captured by traditional gene expression analysis, potentially uncovering new mechanisms of COVID-19 pathogenesis.

What Problem Does This Paper Address?

The COVID-19 pandemic has spurred extensive research into the molecular basis of the disease, primarily focusing on changes in gene expression. However, the role of post-transcriptional regulation, specifically alternative splicing (AS) and alternative polyadenylation (APA), in how viruses reprogram host cells remains less understood. These processes can generate diverse protein isoforms from a single gene, significantly impacting cellular function and disease progression. This paper aims to bridge this knowledge gap by applying novel computational tools to RNA-seq data from SARS-CoV-2 infected lung cells to comprehensively analyze these transcript variants and their relationship with gene expression changes.

Methods

The researchers utilized a suite of computational methods, including their custom-developed pipeline "AS-Quant" for detecting alternative splicing events. This pipeline analyzes RNA-seq read coverage to identify and quantify five major types of AS events (Skipped Exon, Retained Intron, Alternative 3' Splice Site, Alternative 5' Splice Site, and Mutually Exclusive Exon). For alternative polyadenylation, they employed "APA-Scan" to identify 3'-UTR APA events and a custom approach for coding region APA (CR-APA). CR-APA was quantified using a "CR-truncation ratio." Differential gene and transcript expression analysis was performed using Kallisto. Pathway enrichment analysis was conducted using DAVID Bioinformatics Resources to identify over-represented Gene Ontology (GO) terms and KEGG pathways.

Datasets

The study used publicly available RNA-seq data from the NCBI Gene Expression Omnibus (GEO) database, specifically accession number GSE147507. This dataset includes biological triplicates of mock-treated and SARS-CoV-2 infected A549 lung alveolar cells.

Key Insights and Ideas

  • Transcript variants are a distinct layer of viral response: The study highlights that SARS-CoV-2 infection induces significant changes in alternative splicing and polyadenylation that are largely independent of differential gene expression. This suggests that focusing solely on gene expression misses crucial aspects of the host response.
  • AS and APA provide unique molecular signatures: Genes with altered transcript variants can serve as valuable molecular signatures for understanding COVID-19, potentially offering new avenues for diagnostics or therapeutics.
  • Uncovering novel pathways: The analysis revealed enrichment of specific biological pathways (e.g., ribosome, spliceosome) through transcript variant analysis that were not detected by differential gene expression alone, pointing towards new mechanisms of SARS-CoV-2 pathogenesis.
  • Differential impact of AS and APA: While alternative splicing events increased in infected cells, alternative polyadenylation events, particularly UTR-APA, were suppressed. This suggests a complex regulatory interplay.

Key Results

  • Increased Alternative Splicing: SARS-CoV-2 infected cells showed a notable increase in alternative splicing (AS) events compared to mock-treated cells. The Skipped Exon (SE) type was the most prevalent, with 126 events in infected cells versus 51 in mock-treated cells.
  • Suppressed Alternative Polyadenylation: Conversely, UTR-APA events were significantly suppressed in SARS-CoV-2 infected cells (7 events) compared to mock-treated cells (137 events). CR-APA events showed an increase in mock-treated cells (1206) compared to infected cells (656).
  • Weak Correlation with Gene Expression: A significant portion (>88% for UTR-APA and >90% for CR-APA) of genes with APA events were not differentially expressed. Similarly, only a small fraction of differentially expressed genes showed AS events. This underscores the independence of these regulatory mechanisms.
  • Pathway Enrichment: Enriched KEGG pathways in mock-treated cells included ribosome and spliceosome. In SARS-CoV-2 infected cells, pathways related to inflammation, such as TNF-a and NF-kappa signaling, were upregulated, aligning with known cytokine responses in COVID-19 patients.

Limitations and Future Work

The authors acknowledge that their findings are confined to the transcriptome level. They suggest that future investigations should extend to proteome changes and post-translational modifications to gain a more comprehensive understanding of COVID-19 pathobiology. They also note that their AS-Quant pipeline's reliance on annotations might limit the discovery of intron retention events, which could produce novel peptides. Further research into these non-canonical peptides is recommended. The study also points to the need for multi-omics approaches to fully resolve the molecular and cellular signatures of COVID-19.

Summary updated

Abstract

Microbes and viruses are known to alter host transcriptomes by means of infection. In light of recent challenges posed by the COVID-19 pandemic, a deeper understanding of the disease at the transcriptome level is needed. However, research about transcriptome reprogramming by post-transcriptional regulation is very limited. In this study, computational methods developed by our lab were applied to RNA-seq data to detect transcript variants (i.e., alternative splicing (AS) and alternative polyadenylation (APA) events). The RNA-seq data were obtained from a publicly available source, and they consist of mock-treated and SARS-CoV-2 infected (COVID-19) lung alveolar (A549) cells. Data analysis results show that more AS events are found in SARS-CoV-2 infected cells than in mock-treated cells, whereas fewer APA events are detected in SARS-CoV-2 infected cells. A combination of conventional differential gene expression analysis and transcript variants analysis revealed that most of the genes with transcript variants are not differentially expressed. This indicates that no strong correlation exists between differential gene expression and the AS/APA events in the mock-treated or SARS-CoV-2 infected samples. These genes with transcript variants can be applied as another layer of molecular signatures for COVID-19 studies. In addition, the transcript variants are enriched in important biological pathways that were not detected in the studies that only focused on differential gene expression analysis. Therefore, the pathways may lead to new molecular mechanisms of SARS-CoV-2 pathogenesis.
BibTeX
@article{sun2021computational,
  author = {Jiao Sun and Naima Ahmed Fahmi and Heba Nassereddeen and Sze Cheng and Irene Martinez and Deliang Fan and Jeongsik Yong and Wei Zhang},
  title = {{Computational Methods to Study Human Transcript Variants in COVID-19 Infected Lung Cancer Cells}},
  journal = {International Journal of Molecular Sciences},
  year = {2021},
  doi = {10.3390/ijms22189684},
}
Figure